REZUROCK

LIVE

Serial Number

88401751

Owner

Kadmon Pharmaceuticals, LLC

Attorney

Michael J. Leonard

First Use Date

Aug 17, 2021

Filing Date

Apr 25, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

REZUROCK Trademark

Serial Number: 88401751 • Registration: 6654082

REZUROCK is a trademark filed by Kadmon Pharmaceuticals, LLC on April 25, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Kadmon Pharmaceuticals, LLC (28 trademarks)

400 Madison Avenue
New York, NY 10017

Entity Type: 16

Legal Representation

Attorney of Record

Michael J. Leonard

4,085 trademarks filed View all →

Trademark Details

Filing Date

April 25, 2019

Registration Date

February 22, 2022

First Use Anywhere

August 17, 2021

First Use in Commerce

August 17, 2021

Published for Opposition

February 25, 2020

Goods & Services

Pharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical products for the prevention and treatment of respiratory diseases

Filing History

REGISTERED-PRINCIPAL REGISTER

Feb 22, 2022 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 20, 2022 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 19, 2022 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Sep 14, 2021 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 13, 2021 AITU

USE AMENDMENT FILED

Sep 2, 2021 IUAF

TEAS STATEMENT OF USE RECEIVED

Sep 2, 2021 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 22, 2021 EXRA

SOU EXTENSION 2 GRANTED

Apr 20, 2021 EX2G

SOU EXTENSION 2 FILED

Apr 20, 2021 EXT2

SOU TEAS EXTENSION RECEIVED

Apr 20, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 23, 2020 EXRA

SOU EXTENSION 1 GRANTED

Oct 21, 2020 EX1G

SOU EXTENSION 1 FILED

Oct 21, 2020 EXT1

SOU TEAS EXTENSION RECEIVED

Oct 21, 2020 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 21, 2020 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 25, 2020 NPUB

PUBLISHED FOR OPPOSITION

Feb 25, 2020 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 5, 2020 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 23, 2020 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 16, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 15, 2020 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 15, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 16, 2019 GNRN

NON-FINAL ACTION E-MAILED

Jul 16, 2019 GNRT

NON-FINAL ACTION WRITTEN

Jul 16, 2019 CNRT

ASSIGNED TO EXAMINER

Jul 8, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 10, 2019 NWOS

NEW APPLICATION ENTERED

Apr 29, 2019 NWAP

Related Trademarks

More from this Owner

IMMUNITAIRE

KADMONASSIST

RHOLISTIQ

More in Same Class

BÜ BLÜHEN BOTANICALS

INSPIRED IN IRELAND SINCE 1922 MUSHATT'S NO. 9 MEDICATED SKIN THERAPY